Comparative Effectiveness of Endovascular Treatment for Acute Ischemic Stroke: A Population‐Based Analysis

Author:

Zerna Charlotte12,Rogers Edwin3,Rabi Doreen M.24,Demchuk Andrew M.156,Kamal Noreen7,Mann Balraj8,Jeerakathil Tom9,Buck Brian9,Shuaib Ashfaq9,Rempel Jeremy10,Menon Bijoy K15,Goyal Mayank16,Hill Michael D.1526

Affiliation:

1. Department of Clinical Neurosciences Cumming School of Medicine University of Calgary Alberta Canada

2. Department of Community Health Sciences University of Calgary Alberta Canada

3. Clinical Analytics Alberta Health Services Edmonton Alberta Canada

4. Department of Medicine Cumming School of Medicine University of Calgary Alberta Canada

5. Hotchkiss Brain Institute University of Calgary Alberta Canada

6. Department of Radiology Cumming School of Medicine University of Calgary Alberta Canada

7. Department of Industrial Engineering Dalhousie University Halifax Nova Scotia Canada

8. Cardiovascular Health and Stroke Strategic Clinical Network Alberta Health Services Edmonton Alberta Canada

9. Division of Neurology Department of Medicine University of Alberta Edmonton Alberta Canada

10. Department of Radiology and Diagnostic Imaging University of Alberta Edmonton Alberta Canada

Abstract

Background A heterogeneous patient population receives endovascular treatment ( EVT ) for acute ischemic stroke caused by proximal large‐vessel occlusion every day. We aimed to conduct a population‐based study of EVT in the province of Alberta, Canada, to understand the effectiveness in a complete population and how the magnitude of effect differs from the artificial world of clinical trials. Methods and Results Within a 3‐year period (April 2015 to March 2018), 576 patients fit the inclusion criteria of our study and constituted the EVT group of our analysis. The medical treatment group of the ESCAPE (Endovascular Treatment for Small Core and Anterior Circulation Proximal Occlusion With Emphasis on Minimizing CT [Computed Tomography] to Recanalization Times) trial had 150 patients. Thus, our total sample size was 726. We captured outcomes in clinical routine using administrative data and a linked database method. Primary outcome of our study was home‐time. Home‐time refers to the number of days that the patient was back at premorbid living situation without increase in level of care within 90 days of index stroke event. Median age of patients was 70 years (interquartile range, 59–81 years), and 47.8% were women. Median National Institutes of Health Stroke Scale score was 17 (interquartile range, 13–20). EVT was associated with an increased 90‐day home‐time by an average of 8.5 days compared with medical treatment alone using Cragg hurdle regression ( P =0.009). Age and higher National Institutes of Health Stroke Scale score were associated with decreased 90‐day home‐time (both P <0.001). Multivariable logistic regression showed no association between EVT and mortality at 90 days (odds ratio, 0.76; 95% CI, 0.47–1.24). Conclusions EVT for acute ischemic stroke caused by proximal large‐vessel occlusion was effective in our province‐wide population‐based study and results in an increase of 90‐day home‐time by ~8.5 days.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3